-
1
-
-
0034958124
-
Fenofibrate and warfarin interaction
-
Aldridge MA, Ito MK. Fenofibrate and warfarin interaction. Pharmacotherapy 2001;21(7):886-9. (Pubitemid 32606803)
-
(2001)
Pharmacotherapy
, vol.21
, Issue.7
, pp. 886-889
-
-
Aldridge, M.A.1
Ito, M.K.2
-
2
-
-
29144471067
-
Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic oral anticoagulant treatment
-
Castori L, Taliani MR, Agnelli G, Boschetti E, Gresele P. Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic OAC treatment. Haematologica 2005;90(12):1720-2. (Pubitemid 41815009)
-
(2005)
Haematologica
, vol.90
, Issue.12
, pp. 1720-1722
-
-
Castori, L.1
Taliani, M.R.2
Agnelli, G.3
Boschetti, E.4
Gresele, P.5
-
3
-
-
77954508907
-
CYP4F2 rs2108622: A minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
-
Cen HJ, Zeng WT, Leng XY, Huang M, Chen X, Li JL, et al. CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement. Br J Clin Pharmacol 2010;70(2):234-40.
-
(2010)
Br J Clin Pharmacol.
, vol.70
, Issue.2
, pp. 234-240
-
-
Cen, H.J.1
Zeng, W.T.2
Leng, X.Y.3
Huang, M.4
Chen, X.5
Li, J.L.6
-
4
-
-
0033809508
-
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)
-
Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake D, et al. Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). Am Heart 2000;140(4):631-6.
-
(2000)
Am Heart.
, vol.140
, Issue.4
, pp. 631-636
-
-
Chesney, C.M.1
Elam, M.B.2
Herd, J.A.3
Davis, K.B.4
Garg, R.5
Hunninghake, D.6
-
5
-
-
0035098515
-
Increase in international normalized ratio associated with smoking cessation [1]
-
Colucci VJ, Knapp JF. Increase in international normalized ratio associated with smoking cessation. Ann Pharmacother 2001;35(3):385-6. (Pubitemid 32201727)
-
(2001)
Annals of Pharmacotherapy
, vol.35
, Issue.3
, pp. 385-386
-
-
Colucci, V.J.1
-
6
-
-
0028670856
-
Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials
-
Conly J, Stein K. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med 1994;17:531-9.
-
(1994)
Clin Invest Med.
, vol.17
, pp. 531-539
-
-
Conly, J.1
Stein, K.2
-
7
-
-
0037369563
-
Warfarin and amoxicillin/clavulanate drug interaction
-
Davydov L, Yermolnik M, Cuni LJ. Warfarin and amoxicillin/clavulanate drug interaction. Ann Pharmacother 2003;37(3):367-70. (Pubitemid 36249635)
-
(2003)
Annals of Pharmacotherapy
, vol.37
, Issue.3
, pp. 367-370
-
-
Davydov, L.1
Yermolnik, M.2
Cuni, L.J.3
Rivera-Miranda, G.C.4
Rochefort, E.5
-
8
-
-
80053430583
-
Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients
-
De Oliveira Almeida VC, De Souza Ferreira AC, Ribeiro DD, Gomes Borges KB, Salles Moura Fernandes AP, Brunialti Godard AL. Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients. J Thromb Haemost 2011;9(10):2120-2.
-
(2011)
J Thromb Haemost.
, vol.9
, Issue.10
, pp. 2120-2122
-
-
De Oliveira Almeida, V.C.1
De Souza Ferreira, A.C.2
Ribeiro, D.D.3
Gomes Borges, K.B.4
Salles Moura Fernandes, A.P.5
Brunialti Godard, A.L.6
-
9
-
-
27744575173
-
Functional characterization of novel allelic variants of CYP2C9 recently discovered in Southeast Asians
-
DOI 10.1124/jpet.105.091181
-
DeLozier TC, Lee SC, Coulter SJ, Goh BC, Goldstein JA. Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians. J Pharmacol Exp Ther 2005;315(3):1085-90. (Pubitemid 41635394)
-
(2005)
Journal of Pharmacology and Experimental Therapeutics
, vol.315
, Issue.3
, pp. 1085-1090
-
-
DeLozier, T.C.1
Lee, S.-C.2
Coulter, S.J.3
Goh, B.C.4
Goldstein, J.A.5
-
10
-
-
0037320652
-
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
-
DOI 10.1093/hmg/ddg055
-
Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003;12(3): 205-16. (Pubitemid 36204418)
-
(2003)
Human Molecular Genetics
, vol.12
, Issue.3
, pp. 205-216
-
-
Duan, J.1
Wainwright, M.S.2
Comeron, J.M.3
Saitou, N.4
Sanders, A.R.5
Gelernter, J.6
Gejman, P.V.7
-
11
-
-
27644562751
-
Increase in international normalized ratio after smoking cessation in a patient receiving warfarin
-
DOI 10.1592/phco.2005.25.11.1656
-
Evans M, Lewis GM. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin. Pharmacotherapy 2005;25(11):1656-9. (Pubitemid 41566925)
-
(2005)
Pharmacotherapy
, vol.25
, Issue.11
, pp. 1656-1659
-
-
Evans, M.1
Lewis, G.M.2
-
12
-
-
33344461585
-
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
-
DOI 10.1016/j.ahj.2005.04.017, PII S0002870305004369
-
Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151(3):713-9. (Pubitemid 43290267)
-
(2006)
American Heart Journal
, vol.151
, Issue.3
, pp. 713-719
-
-
Gage, B.F.1
Yan, Y.2
Milligan, P.E.3
Waterman, A.D.4
Culverhouse, R.5
Rich, M.W.6
Radford, M.J.7
-
13
-
-
84877146316
-
Identification and weighting of the most critical ''real-life'' drug-drug interactions with acenocoumarol in a tertiary care hospital
-
Gschwind L, Rollason V, Lovis C, Boehlen F, Bonnabry P, Dayer P, et al. Identification and weighting of the most critical ''real-life'' drug-drug interactions with acenocoumarol in a tertiary care hospital. Eur J Clin Pharmacol 2013;69(3):617-27.
-
(2013)
Eur J Clin Pharmacol.
, vol.69
, Issue.3
, pp. 617-627
-
-
Gschwind, L.1
Rollason, V.2
Lovis, C.3
Boehlen, F.4
Bonnabry, P.5
Dayer, P.6
-
14
-
-
19344366484
-
Systematic overview of warfarin and its drug and food interactions
-
DOI 10.1001/archinte.165.10.1095
-
Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165(10):1095-106. (Pubitemid 40720733)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.10
, pp. 1095-1106
-
-
Holbrook, A.M.1
Pereira, J.A.2
Labiris, R.3
McDonald, H.4
Douketis, J.D.5
Crowther, M.6
Wells, P.S.7
-
15
-
-
59549094940
-
Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement
-
Kim HS, Lee SS, Oh M, Jang YJ, Kim EY, Han IY, et al. Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement. Pharmacogenet Genomics 2009;19(2):103-12.
-
(2009)
Pharmacogenet Genomics.
, vol.19
, Issue.2
, pp. 103-112
-
-
Kim, H.S.1
Lee, S.S.2
Oh, M.3
Jang, Y.J.4
Kim, E.Y.5
Han, I.Y.6
-
17
-
-
33846504706
-
A "silent" polymorphism in the MDR1 gene changes substrate specificity
-
DOI 10.1126/science.1135308
-
Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, et al. A ''silent'' polymorphism in the MDR1 gene changes substrate specificity. Science 2007;315(5811):525-8. (Pubitemid 46175758)
-
(2007)
Science
, vol.315
, Issue.5811
, pp. 525-528
-
-
Kimchi-Sarfaty, C.1
Oh, J.M.2
Kim, I.-W.3
Sauna, Z.E.4
Calcagno, A.M.5
Ambudkar, S.V.6
Gottesman, M.M.7
-
18
-
-
49849105411
-
Laboratory and clinical outcomes of pharmacogenetic vs
-
Lenzini PA, GriceGR, Milligan PE,DowdMB, Subherwal S, Deych E, et al. Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients. J Thromb Haemost 2008;6(10):1655-62.
-
(2008)
Clinical Protocols for Warfarin Initiation in Orthopedic Patients. J Thromb Haemost.
, vol.6
, Issue.10
, pp. 1655-1662
-
-
Lenzini, P.A.1
Grice, G.R.2
Milligan, P.E.3
Dow, D.M.B.4
Subherwal, S.5
Deych, E.6
-
19
-
-
84866706420
-
Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients
-
Li JH, Ma GG, Zhu SQ, Yan H, Wu YB, Xu JJ. Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients. J Cardiothorac Surg 2012;7:97.
-
(2012)
J Cardiothorac Surg.
, vol.7
, pp. 97
-
-
Li, J.H.1
Ma, G.G.2
Zhu, S.Q.3
Yan, H.4
Wu, Y.B.5
Xu, J.J.6
-
20
-
-
84899623426
-
Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy
-
Liu Y, Zhong SL, Tan HH, Yang M, Fei HW, Yu XY, et al. Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy. Zhonghua Xin Xue Guan Bing Za Zhi 2011;39(10):929-35.
-
(2011)
Zhonghua Xin Xue Guan Bing Za Zhi.
, vol.39
, Issue.10
, pp. 929-935
-
-
Liu, Y.1
Zhong, S.L.2
Tan, H.H.3
Yang, M.4
Fei, H.W.5
Yu, X.Y.6
-
21
-
-
84875260950
-
Influence of warfarin doseassociated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin
-
Ma C, Zhang Y, Xu Q, Yang J, Zhang Y, Gao L, et al. Influence of warfarin doseassociated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin. Int J Hematol 2012;96(6):719-28.
-
(2012)
Int J Hematol.
, vol.96
, Issue.6
, pp. 719-728
-
-
Ma, C.1
Zhang, Y.2
Xu, Q.3
Yang, J.4
Zhang, Y.5
Gao, L.6
-
22
-
-
33747332776
-
Cytochrome P4502C9 polymorphism and acenocoumarol therapy
-
Mark L,Marki-Zay J, Fodor L,Hajdara I, ParaghG, KatonaA.Cytochrome P4502C9 polymorphism and acenocoumarol therapy. Kardiol Pol 2006;64:397-402.
-
(2006)
Kardiol Pol.
, vol.64
, pp. 397-402
-
-
Mark, L.1
Marki-Zay, J.2
Fodor, L.3
Hajdara, I.4
Paragh, G.5
Katona, A.6
-
23
-
-
65249102147
-
Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects
-
Matimba A, Del-Favero J, Van Broeckhoven C, Masimirembwa C. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects. Hum Genomics 2009;3(2):169-90.
-
(2009)
Hum Genomics.
, vol.3
, Issue.2
, pp. 169-190
-
-
Matimba, A.1
Del-Favero, J.2
Van Broeckhoven, C.3
Masimirembwa, C.4
-
24
-
-
66849132349
-
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant
-
McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 2009 75 6 1337-1346.
-
(2009)
Mol Pharmacol.
, vol.75
, Issue.6
, pp. 1337-1346
-
-
McDonald, M.G.1
Rieder, M.J.2
Nakano, M.3
Hsia, C.K.4
Rettie, A.E.5
-
25
-
-
0022356826
-
Population kinetics of racemic warfarin
-
Mungall DR, Ludden TM, Marshall J, Hawkins W, Talbert RL, Crawford MH. Population kinetics of racemic warfarin. J Pharmacokinet Biopharm 1985;13: 213-27.
-
(1985)
J Pharmacokinet Biopharm.
, vol.13
, pp. 213-227
-
-
Mungall, D.R.1
Ludden, T.M.2
Marshall, J.3
Hawkins, W.4
Talbert, R.L.5
Crawford, M.H.6
-
26
-
-
84902314971
-
Genetic Bleeding Risk Score (GBRS) for patients on oral anticoagulant therapy
-
Nahar R, Verma IC, Deb R, Saxena R, Takkar P, Shad S, et al. Genetic Bleeding Risk Score (GBRS) for patients on oral anticoagulant therapy. International Journal of Genomic Medicine 2013. 1:101.
-
(2013)
International Journal of Genomic Medicine.
, vol.1
, pp. 101
-
-
Nahar, R.1
Verma, I.C.2
Deb, R.3
Saxena, R.4
Takkar, P.5
Shad, S.6
-
27
-
-
33746613172
-
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: A retrospective analysis of case records
-
DOI 10.1111/j.1538-7836.2006.02039.x
-
Osman A, EnströmC, Arbring K, Sö derkvist P, Lindahl TL. Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records. J Thromb Haemost 2006;4(8):1723-9. (Pubitemid 44144799)
-
(2006)
Journal of Thrombosis and Haemostasis
, vol.4
, Issue.8
, pp. 1723-1729
-
-
Osman, A.1
Enstrom, C.2
Arbring, K.3
Soderkvist, P.4
Lindahl, T.L.5
-
28
-
-
79952176479
-
Interactions between natural health products and oral anticoagulants: Spontaneous reports in the Italian Surveillance System of Natural Health Products
-
Paoletti A, Gallo E, Benemei S, Vietri M, Lapi F, Volpi R, et al. Interactions between natural health products and oral anticoagulants: spontaneous reports in the Italian Surveillance System of Natural Health Products. Evid Based Complement Alternat Med 2011;2011:612150.
-
(2011)
Evid Based Complement Alternat Med.
, vol.2011
, pp. 612150
-
-
Paoletti, A.1
Gallo, E.2
Benemei, S.3
Vietri, M.4
Lapi, F.5
Volpi, R.6
-
29
-
-
72849127064
-
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients
-
Pautas E, Moreau C, Gouin-Thibault I, Golmard JL, Mahé I, Legendre C, et al. Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients. Clin Pharmacol Ther 2010;87(1):57-64.
-
(2010)
Clin Pharmacol Ther.
, vol.87
, Issue.1
, pp. 57-64
-
-
Pautas, E.1
Moreau, C.2
Gouin-Thibault, I.3
Golmard, J.L.4
Mahé, I.5
Legendre, C.6
-
30
-
-
38349134238
-
Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants
-
Penning-van Beest FJ, Koerselman J, Herings RM. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J Thromb Haemost 2008;6(2):284-90.
-
(2008)
J Thromb Haemost.
, vol.6
, Issue.2
, pp. 284-290
-
-
Penning-Van Beest, F.J.1
Koerselman, J.2
Herings, R.M.3
-
31
-
-
0034979678
-
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs
-
DOI 10.1067/mcp.2001.115723
-
Penning-van Beest FJ, van Meegen E, Rosendaal FR, Stricker BH. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther 2001;69(6):451-7. (Pubitemid 32554551)
-
(2001)
Clinical Pharmacology and Therapeutics
, vol.69
, Issue.6
, pp. 451-457
-
-
Penning-Van Beest, F.J.A.1
Van Meegen, E.2
Rosendaal, F.R.3
Stricker, B.H.4
-
32
-
-
66549110050
-
Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy
-
Pérez-Andreu V, Roldán V, Antón AI, Garcá-Barberá N, Corral J, Vicente V, et al. Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. Blood 2009;113(20):4977-9.
-
(2009)
Blood.
, vol.113
, Issue.20
, pp. 4977-4979
-
-
Pérez-Andreu, V.1
Roldán, V.2
Antón, A.I.3
Garcá-Barberá, N.4
Corral, J.5
Vicente, V.6
-
33
-
-
0028210729
-
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
-
Rettie AE, Wienkers LC, Gonzalez FJ, Trager WF, Korzekwa KR. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics 1994;4:39-42. (Pubitemid 24106122)
-
(1994)
Pharmacogenetics
, vol.4
, Issue.1
, pp. 39-42
-
-
Rettie, A.E.1
Wienkers, L.C.2
Gonzalez, F.J.3
Trager, W.F.4
Korzekwa, K.R.5
-
34
-
-
78649342646
-
Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
-
Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010;8(10):2182-91.
-
(2010)
J Thromb Haemost.
, vol.8
, Issue.10
, pp. 2182-2191
-
-
Rose, A.J.1
Hylek, E.M.2
Ozonoff, A.3
Ash, A.S.4
Reisman, J.I.5
Berlowitz, D.R.6
-
35
-
-
36248936550
-
Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements
-
DOI 10.1111/j.1365-2710.2007.00870.x
-
Saraeva RB, Paskaleva ID, Doncheva E, Eap CB, Ganev VS. Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements. J Clin Pharm Ther 2007;32(6):641-9. (Pubitemid 350135117)
-
(2007)
Journal of Clinical Pharmacy and Therapeutics
, vol.32
, Issue.6
, pp. 641-649
-
-
Saraeva, R.B.1
Paskaleva, I.D.2
Doncheva, E.3
Eap, C.B.4
Ganev, V.S.5
-
36
-
-
74549205313
-
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk
-
Schelleman H, Bilker WB, Brensinger CM,Wan F, Yang YX, Hennessy S. Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am JMed 2010;123(2):151-7.
-
(2010)
Am JMed.
, vol.123
, Issue.2
, pp. 151-157
-
-
Schelleman, H.1
Bilker, W.B.2
Brensinger, C.M.3
Wan, F.4
Yang, Y.X.5
Hennessy, S.6
-
37
-
-
34247215617
-
Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians
-
DOI 10.1038/sj.clpt.6100144, PII 6100144
-
Schelleman H, Chen Z, Kealey C, Whitehead AS, Christie J, Price M, et al. Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians. Clin Pharmacol Ther 2007;81(5):742-7. (Pubitemid 46625114)
-
(2007)
Clinical Pharmacology and Therapeutics
, vol.81
, Issue.5
, pp. 742-747
-
-
Schelleman, H.1
Chen, Z.2
Kealey, C.3
Whitehead, A.S.4
Christie, J.5
Price, M.6
Brensinger, C.M.7
Newcomb, C.W.8
Thorn, C.F.9
Samaha, F.F.10
Kimmel, S.E.11
-
38
-
-
33751255101
-
Development of a contemporary bleeding risk model for elderly warfarin recipients
-
DOI 10.1378/chest.130.5.1390
-
Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 2006;130:1390-6. (Pubitemid 44786731)
-
(2006)
Chest
, vol.130
, Issue.5
, pp. 1390-1396
-
-
Shireman, T.I.1
Mahnken, J.D.2
Howard, P.A.3
Kresowik, T.F.4
Hou, Q.5
Ellerbeck, E.F.6
-
39
-
-
55449133425
-
Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy
-
Spreafico M, Lodigiani C, van Leeuwen Y, Pizzotti D, Rota LL, Rosendaal F, et al. Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy. Pharmacogenomics 2008;9(9):1237-50.
-
(2008)
Pharmacogenomics.
, vol.9
, Issue.9
, pp. 1237-1250
-
-
Spreafico, M.1
Lodigiani, C.2
Van Leeuwen, Y.3
Pizzotti, D.4
Rota, L.L.5
Rosendaal, F.6
-
40
-
-
0030868485
-
Genetic association between sensitivity to warfarin and expression of CYP2C93
-
DOI 10.1097/00008571-199710000-00004
-
Steward DJ, Haining RL, Henne KR, Davis G, Rushmore TH, Trager WF, et al. Genetic association between sensitivity to warfarin and expression of CYP2C93. Pharmacogenetics 1997;7:361-7. (Pubitemid 27427545)
-
(1997)
Pharmacogenetics
, vol.7
, Issue.5
, pp. 361-367
-
-
Steward, D.J.1
Haining, R.L.2
Henne, K.R.3
Davis, G.4
Rushmore, T.H.5
Trager, W.F.6
Rettie, A.E.7
-
41
-
-
70350754462
-
A genome-wide association study of acenocoumarol maintenance dosage
-
Teichert M, Eijgelsheim M, Rivadeneira F, Uitterlinden AG, van Schaik RH, Hofman A, et al. A genome-wide association study of acenocoumarol maintenance dosage. Hum Mol Genet 2009;18(19):3758-68.
-
(2009)
Hum Mol Genet.
, vol.18
, Issue.19
, pp. 3758-3768
-
-
Teichert, M.1
Eijgelsheim, M.2
Rivadeneira, F.3
Uitterlinden, A.G.4
Van Schaik, R.H.5
Hofman, A.6
-
42
-
-
29244466817
-
Comparative pharmacokinetics of vitamin K antagonists warfarin, phenprocoumon and acenocoumarol
-
DOI 10.2165/00003088-200544120-00003
-
Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clin Pharmacokinet 2005;44(12):1227-46. (Pubitemid 41832565)
-
(2005)
Clinical Pharmacokinetics
, vol.44
, Issue.12
, pp. 1227-1246
-
-
Ufer, M.1
-
43
-
-
0036799042
-
The potential interaction between oral anticoagulants and acetaminophen in everyday practice
-
DOI 10.1023/A:1020555321857
-
van den Bemt PM, Geven LM, Kuitert NA, Risselada A, Brouwers JR. The potential interaction between OACs and acetaminophen in everyday practice. Pharm World Sci 2002;24(5):201-4. (Pubitemid 35204297)
-
(2002)
Pharmacy World and Science
, vol.24
, Issue.5
, pp. 201-204
-
-
Van Den Bemt, P.M.L.A.1
Geven, L.M.2
Kuitert, N.A.3
Risselada, A.4
Brouwers, J.R.B.J.5
-
44
-
-
0033758169
-
Stabilization of OAC therapy in hospitalized patients and characteristics associated with lack of stabilization
-
van den Bemt PM, Joosten P, Risselada A, van den Boogaart MH, Egberts AC, Brouwers JR. Stabilization of OAC therapy in hospitalized patients and characteristics associated with lack of stabilization. Pharm World Sci 2000;22(4):147-51.
-
(2000)
Pharm World Sci.
, vol.22
, Issue.4
, pp. 147-151
-
-
Van Den Bemt, P.M.1
Joosten, P.2
Risselada, A.3
Van Den Boogaart, M.H.4
Egberts, A.C.5
Brouwers, J.R.6
-
45
-
-
80051512500
-
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data
-
van Schie RM, Wessels JA, le Cessie S, de Boer A, Schalekamp T, van der Meer FJ, et al. Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data. Eur Heart J 2011;32(15):1909-17.
-
(2011)
Eur Heart J.
, vol.32
, Issue.15
, pp. 1909-1917
-
-
Van Schie, R.M.1
Wessels, J.A.2
Le Cessie, S.3
De Boer, A.4
Schalekamp, T.5
Van Der Meer, F.J.6
-
46
-
-
20144387370
-
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
-
DOI 10.1160/TH04-08-0542
-
Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, et al. Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype. Thromb Haemost 2005;93(4):700-5. (Pubitemid 40485406)
-
(2005)
Thrombosis and Haemostasis
, vol.93
, Issue.4
, pp. 700-705
-
-
Voora, D.1
Eby, C.2
Linder, M.W.3
Milligan, P.E.4
Bukaveckas, B.L.5
McLeod, H.L.6
Maloney, W.7
Clohisy, J.8
Burnett, R.S.9
Grosso, L.10
Gatchel, S.K.11
Gage, B.F.12
-
47
-
-
59649117935
-
The largest prospective warfarin-treated cohort supports genetic forecasting
-
Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 2009;113(4):784-92.
-
(2009)
Blood.
, vol.113
, Issue.4
, pp. 784-792
-
-
Wadelius, M.1
Chen, L.Y.2
Lindh, J.D.3
Eriksson, N.4
Ghori, M.J.5
Bumpstead, S.6
-
48
-
-
25144433260
-
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
-
Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435CT affects mRNA stability. Pharmacogenet Genomics 2005;15(10):693-704. (Pubitemid 41345321)
-
(2005)
Pharmacogenetics and Genomics
, vol.15
, Issue.10
, pp. 693-704
-
-
Wang, D.1
Johnson, A.D.2
Papp, A.C.3
Kroetz, D.L.4
Sadee, W.5
-
49
-
-
44949092499
-
-
India: Country Profile.
-
WHO Report on the Global Tobacco Epidemic. India: Country Profile; 2011, Available online at: http://www.who.int/tobacco/surveillance/policy/ countryprofile/ind.pdf (accessed 24.04.13).
-
(2011)
WHO Report on the Global Tobacco Epidemic
-
-
-
50
-
-
0035192049
-
Drug interactions update: Drugs, herbs, and oral anticoagulation
-
DOI 10.1023/A:1012742628628
-
Wittkowsky AK. Drug interactions update: drugs, herbs, and oral anticoagulation. J Thromb Thrombolysis 2001;12(1):67-71. (Pubitemid 33103844)
-
(2001)
Journal of Thrombosis and Thrombolysis
, vol.12
, Issue.1
, pp. 67-71
-
-
Wittkowsky, A.K.1
-
51
-
-
3042737049
-
Brief communication: American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled Trial
-
Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med 2004;141(1):23-7.
-
(2004)
Ann Intern Med.
, vol.141
, Issue.1
, pp. 23-27
-
-
Yuan, C.S.1
Wei, G.2
Dey, L.3
Karrison, T.4
Nahlik, L.5
Maleckar, S.6
-
52
-
-
24944503322
-
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
-
DOI 10.1093/hmg/ddi180
-
Yuan HY, Chen JJ, Lee MT, Wung JC, Chen YF, Charng MJ, et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet 2005;14(13):1745-51. (Pubitemid 41430097)
-
(2005)
Human Molecular Genetics
, vol.14
, Issue.13
, pp. 1745-1751
-
-
Yuan, H.-Y.1
Chen, J.-J.2
Lee, M.T.M.3
Wung, J.-C.4
Chen, Y.-F.5
Charng, M.-J.6
Lu, M.-J.7
Hung, C.-R.8
Wei, C.-Y.9
Chen, C.-H.10
Wu, J.-Y.11
Chen, Y.-T.12
|